Trademark Overview
On Thursday, June 25, 2026, a trademark application was filed for CORVENTIS with the United States Patent and Trademark Office. The USPTO has given the CORVENTIS trademark a serial number of 99904994. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Thursday, June 25, 2026. This trademark is owned by Atrium Therapeutics, Inc.. The CORVENTIS trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:
oligonucleotide-conjugate based therapies, oligonucleotide-antibody conjugate based therapies, and oligonucleotide-antibody fragment conjugate based therapies for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, neuromuscular, rare muscle diseases, cardiomyopathies, heart muscle diseases, muscular dystrophies, muscle atrophy, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders
Medical and scientific research, namely, conducting clinical trials; providing medical and scientific research information in the fields of pharmaceuticals, biotechnology, and clinical trials; pharmaceutical research and development; pharmaceutical products development; research and development in the field of biotechnology
